Farming – Agri-Finance · Editorial

By Moakanyi Magazine · June 2026

The textbook response to a foot-and-mouth outbreak has long been the cull, a blunt instrument that protects the wider herd by destroying the infected one. During a May 2024 outbreak, Botswana authorities chose a different path, opting to vaccinate the cattle rather than depopulate them, easing farmer anxieties while accepting heavier vaccine and monitoring needs.

The choice trades one set of costs for another. Culling delivers a fast, visible end to an outbreak at the price of destroyed livelihoods; vaccination preserves the herd and the farmer's stake but demands sustained vaccine supply and surveillance to prove the disease is contained. Neither path is free, and the decision is really about who carries the cost and over what horizon.

The Choice: Herd Preserved, Burden Shifted

Vaccinating instead of culling keeps animals alive and keeps farming households whole, which is no small thing in cattle-rearing communities where a herd is both income and standing. In much of Botswana, cattle are savings, status and social security at once, so a depopulation order is not only an economic loss but a social rupture. The decision reads as a humane one, and it visibly eased the anxiety that a mass cull would have caused.

But the burden does not vanish; it moves. A vaccinate-and-monitor approach requires enough doses, delivered on time, and a monitoring system rigorous enough to confirm that the outbreak is truly under control rather than merely masked by partial immunity. Vaccination can suppress symptoms while the virus still circulates, so the surveillance has to be good enough to tell containment from concealment. That is a quieter, longer and more demanding obligation than a cull, and it falls on the veterinary system rather than the individual farmer.

Vaccinating instead of culling keeps the herd alive and moves the cost from the farmer to the system.

The Catch: Vaccination and the EU Disease Line

There is a market dimension the humane case has to sit alongside. The EU's premium beef access rests on foot-and-mouth zoning, where freedom from the disease without vaccination carries the highest status, and where a zone that vaccinates may face a longer and more exacting path back to export certification. Choosing to vaccinate eases the immediate human cost, but it raises monitoring demands precisely because export status turns on demonstrable, documented disease control.

That tension is the heart of the policy. The vaccinate-not-depopulate approach answers the question of how to treat farmers humanely, while sharpening the question of how to keep the surveillance credible enough to protect the export status the whole sector depends on. A decision that protects the herd in May can still threaten the EU price later if the monitoring behind it cannot satisfy the certification rules. The humane choice and the market choice are not automatically the same choice, and reconciling them is the real work.

A humane response to FMD only holds if the monitoring behind it stays credible to the market.

The Operator's Read: Cost Deferred, Not Avoided

For the beef value chain, the May 2024 decision is a study in trade-offs rather than a clean win. The cost of an outbreak is not removed by choosing vaccination; it is deferred and reshaped into a standing demand for doses, cold chain, field teams and records. A system that funds the vaccine but underfunds the monitoring buys the humane outcome and risks the market one, which is the worst of both ledgers.

There is a governance signal in the choice as well. Opting to vaccinate rather than cull is a bet on the state's own delivery capacity, because the humane path only stays humane if the doses, the cold chain and the field records actually arrive and hold up. A cull needs resolve for a few hard weeks; a vaccinate-and-monitor strategy needs reliable execution for months. The decision therefore commits the veterinary system to a standard of follow-through that is easy to announce and harder to sustain, and the gap between the two is where a humane policy can quietly turn into a market liability.

Botswana chose to protect its farmers from depopulation and, in doing so, took on the harder, quieter obligation of sustained vaccination and monitoring. In the cattle economy, a humane choice is only as durable as the system that backs it, and the real test of the May 2024 decision will be measured not in the animals saved that month but in the export certification held in the months that follow.

Sources: allAfrica